脂质体药物输送市场基于(主要区域、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00010407
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

2021 年,脂质体药物输送市场估值为 42 亿美元,预计到 2031 年将达到 115 亿美元。预计 2023 年至 2031 年,该市场的复合年增长率为 8.3%。快速的监管批准可能仍然是脂质体药物输送市场的关键趋势。

 

脂质体给药市场分析

 

癌症治疗中的脂质体药物递送

脂质体因其广泛的应用而彻底改变了癌症治疗。例如,脂质体由于其生物相容性和生物降解性特性,是第一个被批准用于临床应用的基于纳米技术的药物递送系统。此外,脂质体已在基于纳米载体的药物递送系统中建立了自己的地位,成功地将脂质体制剂用于抗癌治疗的临床应用。此外,脂质体药物具有高封装特性,通过降低毒性,特别是心脏毒性,显示出显着的抗癌活性。这种脂质体治疗封装技术(封装)显示出类似于“柔红霉素”和“聚乙二醇化脂质体多柔比星”的极大延长的循环。上述因素对 2021-2031 年脂质体药物递送市场的增长产生了影响。

 

脂质体药物递送市场概述

技术、创新和智能技术解决方案等继续对脂质体药物输送产生重大影响。癌症治疗中的脂质体药物递送和脂质体药物递送的高效产品推出是脂质体药物递送市场增长的最有影响力的因素。快速监管批准是脂质体给药市场增长的关键趋势。研究与开发(R&D)活动将提供利润丰厚的市场机会。

 

定制研究以满足您的要求

我们可以优化和定制我们的标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

脂质体药物输送市场:

脂质体药物递送市场

  • 年均复合增长率(2023 - 2031)
    8.3%
  • 2021 年市场规模
    42 亿美元
  • 2031 年市场规模
    115 亿美元

市场动态

增长动力
  • 癌症治疗中的脂质体药物递送
未来的趋势
  • 快速的监管审批
机会
  • 研究与开发 (R&D) 活动

关键人物;主力;重要一员

  • 武田药品工业株式会社、
  • 诺华公司,
  • 绿叶制药集团、
  • 益普森制药公司,
  • 赛西恩公司
  • 安斯泰来制药有限公司,
  • 强生服务公司,
  • Acrotech 生物制药有限公司,
  • 吉利德科学公司,
  • 太阳制药,

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 脂质体阿霉素
  • 脂质体紫杉醇
  • 脂质体两性霉素B
  • 其他的
技术
  • 隐形脂质体技术
  • 非聚乙二醇化脂质体技术
  • DepoFoam 脂质体技术
  • 溶血脂热敏脂质体
应用
  • 真菌病
  • 癌症治疗
  • 疼痛管理
  • 病毒疫苗
  • 光动力疗法
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

脂质体药物输送市场驱动因素和机遇

 

高效的脂质体药物输送产品上市,受到市场青睐

  • 2021年10月,赢创宣布推出下一代“LIPEX EXTRUDER”,用于快速有效的脂质体药物制造。 LIPEX 为脂质体药物递送制剂提供高通量和更快的批量生产时间。
  • 2022 年 1 月,辉瑞和 Acuitas Therapeutics 宣布就 Acuita 的“脂质纳米粒子(LNP)技术”进行战略合作,以实现其潜在利用。该技术为疫苗和治疗方法的开发带来了希望,重点体现了辉瑞对创新解决方案的承诺,并为该领域的新颖进展提供了资金。

因此,高效的产品发布和脂质体药物输送的战略合作将在未来几年做出重大贡献。

 

脂质体药物输送市场的研发 (R&D) 活动——一个机会

开发脂质体药物输送的顶级制造商正在利用重点研发活动来开发纳米材料、纳米球、脂质体和纳米颗粒。这种脂质体药物递送可以利用体内和体外药物活性进行常规临床实践。自从第一代脂质体被发现以来,脂质纳米颗粒(LNP)已经发生了巨大的发展,在制药行业得到了广泛的采用。例如,刺激响应脂质体是目前正在研究的另一种方法,可增强肿瘤中的药物递送,而它们被设计为在某些理化或生化刺激下释放。例子包括“阿霉素”、“5-氟尿嘧啶”和“AMD3100”。此外,未来的研究涉及许多1/2期临床试验,目前正在研究LNP制剂作为实体瘤的癌症免疫治疗靶点,包括黑色素瘤、成人胶质母细胞瘤、胃肠道癌和泌尿生殖系统癌,重点是广泛的临床应用。因此,研发活动为脂质体药物输送市场提供了利润丰厚的市场机会,在未来几年占据相当大的市场份额。

 

脂质体药物递送

市场报告细分分析

有助于脂质体药物输送市场分析的关键部分是候选资格和服务。

  • 根据产品,脂质体给药市场分为脂质体阿霉素、脂质体紫杉醇、脂质体两性霉素b等。到2023年,脂质体阿霉素可能会占据更大的市场份额。
  • 根据技术,脂质体给药市场分为隐形脂质体技术、非聚乙二醇化脂质体技术、消泡脂质体技术、溶血脂热敏脂质体。到2023年,隐形脂质体技术可能会占据更大的市场份额。
  • 根据应用,脂质体药物输送市场分为真菌疾病、癌症治疗、疼痛管理、病毒疫苗和光动力疗法。到2023年,癌症治疗可能会占据更大的市场份额。

 

按地区划分的脂质体药物递送市场份额分析

脂质体药物输送市场报告的地理范围主要分为五个区域:北美、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。

北美主导了脂质体药物输送市场。在北美,美国在脂质体药物递送方面占据相当大的份额。美国顶尖医疗生物技术和生物制药企业的存在。此外,合同研究组织(CRO)的存在是对市场增长最有影响力的因素之一。预计亚太地区未来几年将以最高的复合年增长率增长。  

 

脂质体药物递送

市场报告范围

报告属性细节
2021年市场规模42亿美元
2031 年市场规模115亿美元
全球复合年增长率(2023 - 2031)8.3%
历史数据2021-2022
预测期2023-2031
涵盖的细分市场按产品分类
  • 脂质体阿霉素
  • 脂质体紫杉醇
  • 脂质体两性霉素B
  • 其他的
按技术
  • 隐形脂质体技术
  • 非聚乙二醇化脂质体技术
  • DepoFoam 脂质体技术
  • 溶血脂热敏脂质体
按申请
  • 真菌病
  • 癌症治疗
  • 疼痛管理
  • 病毒疫苗
  • 光动力疗法
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 武田药品工业株式会社、
  • 诺华公司,
  • 绿叶制药集团、
  • 益普森制药公司,
  • 赛西恩公司
  • 安斯泰来制药有限公司,
  • 强生服务公司,
  • Acrotech 生物制药有限公司,
  • 吉利德科学公司,
  • 太阳制药,
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

脂质体药物输送市场新闻和最新动态

脂质体药物输送市场是通过收集初级和二级研究后的定性和定量数据进行评估的,其中包括重要的公司出版物、协会数据和数据库。以下是脂质体药物输送市场的发展和策略:

  • 2022 年 6 月,Endo Internal Plc 的子公司“Endo Ventures Limited (EVL)”和台湾脂质体股份有限公司 (TLC) 宣布合作将 TLC 的研究产品“TLC599”商业化。目前,TLC599 是一种注射化合物,旨在解决骨关节炎膝盖疼痛,展示了在治疗领域推进治疗方案的不断努力。

 

脂质体药物输送市场报告范围和交付成果

《脂质体药物输送市场规模和预测(2021-2031)》报告对涵盖以下领域的市场进行了详细分析:

  • 范围内涵盖的所有关键细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,例如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析,涵盖主要市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports